aTyr Pharma (NASDAQ:LIFE) reported quarterly losses of $(0.46) per share which met the analyst consensus estimate. This is a 9.52 percent decrease over losses of $(0.42) per share from the same period last year.
Why Pardes Biosciences Shares Are Rising Monday
Pardes Biosciences Inc (NASDAQ: PRDS) shares are trading higher Monday after MediPacific agreed to acquire the company.